Found: 13
Select item for more details and to access through your institution.
Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 347, doi. 10.1007/s10637-008-9135-2
- By:
- Publication type:
- Article
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 355, doi. 10.1007/s10637-008-9137-0
- By:
- Publication type:
- Article
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 339, doi. 10.1007/s10637-008-9133-4
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 331, doi. 10.1007/s10637-008-9129-0
- By:
- Publication type:
- Article
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 387, doi. 10.1007/s10637-008-9126-3
- By:
- Publication type:
- Article
A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 381
- By:
- Publication type:
- Article
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 393, doi. 10.1007/s10637-008-9125-4
- By:
- Publication type:
- Article
Identification of small molecules inducing apoptosis by cell-based assay using fission yeast deletion mutants.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 299, doi. 10.1007/s10637-007-9100-5
- By:
- Publication type:
- Article
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 369, doi. 10.1007/s10637-008-9123-6
- By:
- Publication type:
- Article
Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 319, doi. 10.1007/s10637-007-9102-3
- By:
- Publication type:
- Article
Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 363, doi. 10.1007/s10637-007-9110-3
- By:
- Publication type:
- Article
Cytotoxic effects of curcumin on osteosarcoma cell lines.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 289, doi. 10.1007/s10637-007-9099-7
- By:
- Publication type:
- Article
The combination of gamma ionizing radiation and 8-Cl-cAMP induces synergistic cell growth inhibition and induction of apoptosis in human prostate cancer cells.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 309, doi. 10.1007/s10637-007-9101-4
- By:
- Publication type:
- Article